Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Arthritis & Rheumatism

• Publication date

  2008-12-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/art.24092PMID 19035419
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• All-cause and cause-specific mortality in rheumatoid arthritis are not greater than expected when treated with tumour necrosis factor antagonists

  2007cited by this paper
• The cardiovascular manifestations of rheumatic diseases

  2006cited by this paper
• Prediction of mortality in rheumatoid arthritis based on disease activity markers.

  2005cited by this paper
• Personal use of hair dyes and risk of cancer: a meta-analysis.

  2005cited by this paper
• Cardiovascular admissions and mortality in an inception cohort of patients with rheumatoid arthritis with onset in the 1980s and 1990s

  2005cited by this paper
• Cardiovascular risk factors in women with and without rheumatoid arthritis.

  2004cited by this paper
• Declines in Mortality From Acute Myocardial Infarction in Successive Incidence and Birth Cohorts of Patients With Rheumatoid Arthritis

  2004cited by this paper
• Death rates and causes of death in patients with rheumatoid arthritis: a population‐based study

  2004cited by this paper
• Novel risk factors for atherosclerosis.

  2004cited by this paper
• All-cause mortality and vascular events among patients with rheumatoid arthritis, osteoarthritis, or no arthritis in the UK General Practice Research Database.

  2003cited by this paper
• National study of cause-specific mortality in rheumatoid arthritis, juvenile chronic arthritis, and other rheumatic conditions: a 20 year followup study.

  2003cited by this paper
• Measuring inconsistency in meta-analyses

  2003cited by this paper
• How should meta‐regression analyses be undertaken and interpreted?

  2002cited by this paper
• Mortality in early inflammatory polyarthritis: cardiovascular mortality is increased in seropositive patients.

  2002cited by this paper
• Mortality in patients with rheumatoid arthritis treated actively from the time of diagnosis

  2002cited by this paper
• Quantifying heterogeneity in a meta‐analysis

  2002cited by this paper
• Decreasing mortality in patients with rheumatoid arthritis: results from a large population based cohort in Sweden, 1964-95.

  2002cited by this paper
• Cognitive and behavioral outcomes of school-aged children who were born preterm: a meta-analysis.

  2002cited by this paper
• Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis.

  2001cited by this paper
• Total Mortality is Increased in Rheumatoid Arthritis. A 17-Year Prospective Study

  2001cited by this paper
• Recent improvements in survival in patients with rheumatoid arthritis: better outcomes or different study designs?

  2001cited by this paper
• High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors.

  2001cited by this paper
• The New England Journal

  2000cited by this paper
• No increased mortality in patients with rheumatoid arthritis: up to 10 years of follow up from disease onset

  2000cited by this paper
• Novel risk factors for atherosclerosis.

  2000cited by this paper
• Mortality in a cohort of Norwegian patients with rheumatoid arthritis followed from 1977 to 1992.

  2000cited by this paper
• Mortality in rheumatoid arthritis patients with disease onset in the 1980s

  1999cited by this paper
• Extra-articular rheumatoid arthritis: prevalence and mortality.

  1999cited by this paper
• Mortality in early "sawtooth" treated rheumatoid arthritis patients during the first 8-14 years.

  1999cited by this paper
• Longterm mortality outcome in patients with rheumatoid arthritis: early presenters continue to do well.

  1998cited by this paper
• Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in Northern Sweden.

  1997cited by this paper
• Bias in meta-analysis detected by a simple, graphical test

  1997cited by this paper
• The mortality of rheumatoid arthritis.

  1994cited by this paper
• Rheumatoid arthritis and mortality. A longitudinal study in Pima Indians.

  1993cited by this paper
• Combining Information: Statistical Issues and Opportunities for Research

  1993cited by this paper
• Revised criteria for the classification of rheumatoid arthritis.

  1990cited by this paper
• Mortality and survival in rheumatoid arthritis: a 25 year prospective study of 100 patients.

  1990cited by this paper
• Factors predicting a poor life prognosis in rheumatoid arthritis: an eight year prospective study.

  1989cited by this paper
• The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

  1988cited by this paper
• Mortality in rheumatoid arthritis.

  1988cited by this paper
• Publication bias : a problem in interpreting medical data

  1988cited by this paper
• Survival, prognosis, and causes of death in rheumatoid arthritis.

  1986cited by this paper
• Ten year mortality and causes of death in patients with rheumatoid arthritis.

  1985cited by this paper
• Survival and cause of death in rheumatoid arthritis: a 25-year prospective followup.

  1984cited by this paper
• Cause of death in rheumatoid arthritis.

  1984cited by this paper
• Increased mortality in rheumatoid arthritis.

  1982influential reference
• Increased Mortality in Rheumatoid Arthritis: The Use of a Medical Information System for Assessment of Death Risks

  1982cited by this paper
• The epidemiology of rheumatoid arthritis in Rochester, Minnesota: a study of incidence, prevalence, and mortality.

  1980cited by this paper
• Cause of death in patients with rheumatoid arthritis with particular reference to azathioprine.

  1980cited by this paper
• Mortality among arthritics.

  1976influential reference
• [Cause of death: rheumatoid arthritis].

  1976cited by this paper
• The jackknife-a review

  1974cited by this paper
• Survivorship and death in rheumatoid arthritis.

  1970cited by this paper
• Course and Prognosis in Rheumatoid Arthritis

  1964cited by this paper
• Course and Prognosis in Rheumatoid Arthritis *

  1957cited by this paper
• Length of life and cause of death in rheumatoid arthritis.

  1953cited by this paper

• Exploring curcumin and its synthetic derivatives against key genes for therapeutics of rheumatoid arthritis in the Indian population: a computational approach

  2026cites this paper
• Effects of DMARD and Anti-TNF Therapies on Inflammatory Markers, Lipid Profile, and Insulin Resistance in Rheumatoid Arthritis: A Controlled Study

  2026cites this paper
• Cardiovascular Disease Risk Prediction Utilizing Two-Tier Classification Framework Optimized with Adapted Variable Neighborhood Search Algorithm

  2026cites this paper
• Risks of Myocardial Infarction and Mortality in Patients with Incident Rheumatoid Arthritis Compared with a Matched General Population: A Danish Nationwide Cohort Study

  2026cites this paper
• Impact of Variation in APOE on Rheumatoid Arthritis, Psoriasis, and Psoriatic Arthritis: Sequencing and Genotyping in General Population Cohorts

  2026cites this paper
• Early Tamponade Physiology in a Patient with Autoimmune Disease – A Case Report of Circumferential Pericardial Effusion

  2026cites this paper
• Association between dietary polyunsaturated fatty acids and cardiovascular disease in individuals with rheumatoid arthritis.

  2026cites this paper
• Evaluación Del Riesgo Cardiovascular Mediante Ecografía Carótído/Femoral En Pacientes Con Artritis Reumatoide

  2025cites this paper
• DXA and cardiovascular disease in rheumatoid arthritis: A scoping review.

  2025cites this paper
• Post-Translational Modifications of Lipoproteins: Emerging Players Linking Inflammation and Cardiovascular Disease in Rheumatoid Arthritis—A Narrative Review

  2025influential citation
• Bridging the gut and the heart-Exploring pathophysiology, risk factors, and therapeutic implications of cardiovascular disease in inflammatory bowel disease

  2025cites this paper
• The Effects of Inflammation and Treatment on Adiposity, Obesity, and Sarcopenia in Patients with Autoimmune Rheumatic Disease

  2025cites this paper
• Residual Traditional Risk in Non-Traditional Atherosclerotic Diseases

  2025cites this paper
• Tocilizumab Increases Serum Lipids but Does Not Increase Arteriosclerosis, As Measured by Intima-Media Thickness, in Patients With Rheumatoid Arthritis

  2025cites this paper
• Evaluating the Real-World Use of Topical Diclofenac Sodium Gel 1% Using US Longitudinal Electronic Health Records Database: A study supporting OTC switch

  2025cites this paper
• Asymmetric dimethylarginine and vascular injury in rheumatoid arthritis, from capillaries to large vessels: results from a cross-sectional study

  2025cites this paper
• Olokizumab therapy and cardiovascular complications in rheumatoid arthritis

  2025cites this paper
• [The role of exercise therapy in the comprehensive care of patients with rheumatoid arthritis].

  2025cites this paper
• Endocrine Enigmas: Vascular Health in Females Throughout the Lifespan.

  2025cites this paper
• Physical Activity Levels and Barriers in Bangladeshi Rheumatoid Arthritis Patients: Insights from a University Hospital

  2025cites this paper
• Investigating the causal relationship between rheumatoid arthritis and cardiovascular disease: A Mendelian randomization study

  2025cites this paper
• Coffee consumption may suppress development of metabolic syndrome in patients with rheumatoid arthritis -TOMORROW study.

  2025cites this paper
• Rheumatoid Arthritis and Atrial Fibrillation: a Complex Cardiovascular Intersection – Insights from a Retrospective Cohort Study

  2025cites this paper
• Arterial cardiovascular outcomes and venous thromboembolism in patients with primary Sjögren’s syndrome: a Danish cohort study

  2025cites this paper
• Research Progress of Kinesiophobia in Patients with Rheumatoid Arthritis

  2025cites this paper
• The level of soluble receptor of 33 sST2 and subclinical myocardial dysfunction in patients with systemic lupus erythematosus

  2025cites this paper
• Proteomic characterisation of the early rheumatoid arthritis-cardiovascular disease multimorbid axis

  2025cites this paper
• Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk factors in rheumatoid arthritis

  2025cites this paper
• DNA and RNA Methylation in Rheumatoid Arthritis—A Narrative Review

  2025cites this paper
• Avoidable Hospitalizations in Persons With Rheumatoid Arthritis: A Population‐Based Study Using Administrative Data

  2025cites this paper
• Subclinical myocardial changes in rheumatoid arthritis: cardiovascular magnetic resonance evidence of immuno-inflammatory remodeling

  2025cites this paper
• Cardiovascular Risk in Autoimmune Diseases: Mechanisms, Management, and Emerging Evidence

  2025cites this paper
• Assessment of Dyslipidaemia in Patients with Rheumatoid Arthritis: A Retrospective Cross-sectional Study Across Multiple Rheumatology Clinics in the Qassim Region, Saudi Arabia

  2025cites this paper
• Association between life’s essential 8 and risk of rheumatoid arthritis: a cross-sectional study

  2025cites this paper
• Inflammation-Driven Lipid Suppression in Hospitalized Patients: Insights Into the Inflammatory Lipid Paradox From a Retrospective Study

  2025cites this paper
• Identification and management of patients at high-risk for cardiovascular disease in primary prevention

  2025cites this paper
• A Brief Overview on Molecular Aspects of Models for Induction of RA for Target Validation

  2025cites this paper
• Sjogren’s Disease and Elevated Cardiovascular Risk: Mechanisms and Treatment

  2025cites this paper
• Plasma expression of a microRNA panel is differentially associated with 1H-NMR lipoprotein profile in rheumatoid arthritis patients.

  2025cites this paper
• The Role of Fc-like Receptor 3 in the Pathophysiology of Rheumatoid Arthritis

  2025cites this paper
• Trends in Rheumatoid Arthritis Mortality in the United States, 1999–2020

  2025cites this paper
• Cerebrovascular risk in rheumatoid arthritis patients: insights from carotid artery atherosclerosis in the Paracelsus 10,000 study

  2025influential citation
• Risk of Heart Failure in Patients With Immune-Mediated Inflammatory Diseases: A Population-Based Study

  2025cites this paper
• Acute Coronary Syndrome and Rheumatic Disease

  2025cites this paper
• The Metabolic Score for Insulin Resistance (METS-IR), a Predictor of Cardiovascular Events, Relates to Disease Activity in Patients with Rheumatoid Arthritis

  2025cites this paper
• Screening of endothelial dysfunction in rheumatoid arthritis in Black African subjects in the Physiology Department of the Faculty of Medicine of Dakar: a cross-sectional study

  2025cites this paper
• From Joints to the Heart: An Integrated Perspective on Systemic Inflammation

  2025cites this paper
• Spanish Working Group in Crohn’s Disease and Ulcerative Colitis (GETECCU) position paper on cardiovascular disease in patients with inflammatory bowel disease

  2025cites this paper
• Incidence of Major Adverse Cardiovascular Events in Patients With Rheumatoid Arthritis Treated With JAK Inhibitors Compared With Biologic Disease‐Modifying Antirheumatic Drugs: Data From an International Collaboration of Registries

  2025cites this paper
• High Resolution B-Mode Ultrasonography in Evaluation of Atherosclerosis in Patients with Rheumatoid Arthritis

  2025influential citation
• The Fibrosis-4 Index (FIB-4) correlates with cardiovascular risk and insulin resistance in patients with rheumatoid arthritis.

  2025cites this paper
• Risk of major adverse cardiovascular events following targeted therapy in patients with rheumatoid arthritis: a real-world analysis stratified by cardiovascular risk.

  2025cites this paper
• Strategies for assessing and preventing cardiovascular disease risk in inflammatory bowel disease patients: A meta-analysis and meta-regression and bibliometric review

  2025cites this paper
• Statin Use in Special Populations for the Prevention of Cardiovascular Disease in Adults

  2025cites this paper
• Glucagon-like-peptide 1 (GLP-1) Receptor Agonists in Rheumatologic Disease

  2025cites this paper
• New Cardiovascular Risk Biomarkers in Rheumatoid Arthritis: Implications and Clinical Utility—A Narrative Review

  2025cites this paper
• Relationship of Serum 3-Nitrotyrosine Levels with Inflammation in Patients with Rheumatoid Arthritis

  2025cites this paper
• Rapamycin reveals neuropeptide Y as a regulator of senescence and inflammatory pathways in arthritis.

  2025cites this paper
• Relationship between serum vitamin D levels and pro-inflammatory cytokines in patients with rheumatoid arthritis combined with cardiovascular disease

  2025cites this paper
• Emergency department visits for ambulatory care sensitive conditions by persons with Rheumatoid Arthritis: A population-based study

  2025cites this paper
• Rheumatoid arthritis and cardiovascular disease associations in the UK Biobank

  2025cites this paper
• Comparison of PREVENT with the pooled cohort equation for estimating atherosclerotic cardiovascular disease risk among patients with rheumatoid arthritis

  2025cites this paper
• The association between abnormal glucose metabolism and rheumatoid arthritis.

  2025cites this paper
• Correlation of Naples prognostic score with the risk of all-cause and cardiovascular mortality in individuals with rheumatoid arthritis: a cross-sectional analysis of the NHANES 2001-2018.

  2025cites this paper
• Severity and mortality of inflammatory rheumatic diseases: evolution of approaches.

  2025cites this paper
• Higher frequencies of age-associated B-cells in early arthritis are linked to atherosclerosis and immune circuits-a potential role as a biomarker for risk stratification.

  2025cites this paper
• Low adherence to cardiovascular risk assessment guidelines in patients with rheumatoid arthritis: a retrospective chart review of routine clinical practice

  2025cites this paper
• THE IMPACT OF HOMOCYSTEINE IN LUPUS ERYTHEMATOSUS: A LINK OF INFLAMMATION, SKIN AND CARDIOVASCULAR RISK

  2025cites this paper
• Disease knowledge and quality of life among rheumatoid arthritis patients: a cross-sectional study

  2025cites this paper
• Efficacy and safety of low-dose rosuvastatin/ezetimibe for dyslipidemia in patients with rheumatoid arthritis or osteoarthritis

  2025cites this paper
• Mortality and risk factors in Japanese patients with rheumatoid arthritis: a 14-year observation of the IORRA cohort.

  2025cites this paper
• Social significance of rheumatic diseases, negative consequences for the health care system and ways of prevention

  2025cites this paper
• How Can We Reduce Cardiovascular Risk in Women and Improve Risk Stratification?

  2025cites this paper
• Association between tooth loss and mortality in patients with rheumatoid arthritis

  2025cites this paper
• Prognostic impact of rheumatic diseases in patients with heart failure with mildly reduced ejection fraction.

  2025cites this paper
• Is there an association between anti-inflammatory medical treatments for rheumatoid arthritis and mortality after first myocardial infarction?

  2025cites this paper
• Cardiovascular disease risk assessment in patients with rheumatoid arthritis: A scoping review

  2024cites this paper
• Expanding landscape of coronary microvascular disease in co-morbid conditions: Metabolic disease and beyond.

  2024cites this paper
• Risk factors for prevalent and incident hypertension in rheumatoid arthritis: data from the Canadian Early Arthritis Cohort

  2024cites this paper
• Incidence and predisposing factors of extra-articular manifestations in contemporary rheumatoid arthritis.

  2024cites this paper
• A Study of Assessment of Preclinical Atherosclerosis by Carotid Intima-media Thickness in Newly Diagnosed Patients with Rheumatoid Arthritis Younger than 50 Years of Age and Their Correlation with Disease Activity: A Comparative, Cross-sectional Study

  2024cites this paper
• External validation of a multi-biomarker-based score for predicting risk of cardiovascular disease in patients with rheumatoid arthritis

  2024cites this paper
• Analysis of Common Differential Genes and Related Mechanisms of Rheumatoid Arthritis and Acute Myocardial Infarction Based on Bioinformatics

  2024cites this paper
• Angiopoietin-2, vascular endothelial growth factor family, and heparin binding endothelial growth factor are associated with subclinical atherosclerosis in rheumatoid arthritis.

  2024cites this paper
• Implementing a Staff‐Led Smoking Cessation Intervention in a Diverse Safety‐Net Rheumatology Clinic: A Pre‐Post Scalability Study in a Low‐Resource Setting

  2024cites this paper
• Non-Invasive Assessment of Micro- and Macrovascular Function after Initiation of JAK Inhibitors in Patients with Rheumatoid Arthritis

  2024cites this paper
• Cardiovascular risk assessment in inflammatory bowel disease with coronary calcium score

  2024cites this paper
• Cholesterin-Paradoxon: Herzrisiko trotz Norm-LDL bei rheumatoider Arthritis hoch

  2024cites this paper
• Characterizing the polygenic overlap and shared loci between rheumatoid arthritis and cardiovascular diseases

  2024cites this paper
• Association of the multi-biomarker disease activity score with arterial 18-fluorodeoxyglucose uptake in rheumatoid arthritis.

  2024cites this paper
• Risk for cardiovascular disease development in rheumatoid arthritis

  2024influential citation
• Lipid Association of India 2023 update on cardiovascular risk assessment and lipid management in Indian patients: Consensus statement IV.

  2024cites this paper
• Risk of cardiovascular disease decreases over time in psoriatic arthritis but not in spondylarthritis: meta-analysis of longitudinal studies.

  2024cites this paper
• Targeting the vivid facets of apolipoproteins as a cardiovascular risk factor in rheumatoid arthritis.

  2024cites this paper
• Cardiovascular complications of rheumatoid arthritis.

  2024cites this paper
• Rheumatoid arthritis and cardiovascular complications during delivery: a United States inpatient analysis.

  2024cites this paper
• Editorial: Cardiovascular involvement in autoimmune diseases, volume II

  2024cites this paper
• JAK-Inhibitors – A Story of Success and Adverse Events

  2024cites this paper
• Update on sex specific risk factors in cardiovascular disease

  2024cites this paper
• IMPACTO DA INFLAMAÇÃO CRÔNICA NA ATEROSCLEROSE EM PACIENTES COM DOENÇAS REUMÁTICAS AUTOIMUNES

  2024cites this paper